Biopsy Proven and Biopsy Negative Temporal Arteritis: Differences in Clinical Spectrum at the Onset of the Disease

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.58.6.335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Table 2: The Spectrum of Biopsy-Proven Renal Disease in Patients With NDRD.

English

Evaluation for Clinical Predictors of Positive Temporal Artery Biopsy in Giant Cell Arteritis

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2011English

The Modern Spectrum of Biopsy-Proven Renal Disease in Chinese Diabetic Patients—a Retrospective Descriptive Study

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

THU0459 Survival of Biopsy Proven Giant Cell Arteritis in Northern Italy: Correlation With Clinical, Laboratory and Histopathological Findings

2018English

Spectrum of Biopsy Proven Extraocular Muscle Tumours of Non-Thyroid Origin

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Medicine
2019English

Anterior Ischemic Optic Neuropathy Due to Biopsy-Proven Giant Cell Arteritis in Thai Patients

Clinical Ophthalmology
Ophthalmology
2015English

Biopsy-Proven Isolated Sarcoid Meningitis

Journal of Neurosurgery
SurgeryNeurology
1993English

The Impact of Temporal Artery Biopsy for the Diagnosis of Giant Cell Arteritis in Clinical Practice in a Tertiary University Hospital

PLoS ONE
Multidisciplinary
2019English

Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period

Arthritis Care and Research
Rheumatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy